Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Active not recruiting × Lung Diseases × Diarylheptanoids × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Lung Neoplasms 1 Lung Diseases 1

Interventions

Paclitaxel 3 Carboplatin 3 selpercatinib 2 durvalumab 2 Nivolumab 2 Blood Specimen Collection 2 zipalertinib 1 ceralasertib 1 atezolizumab 1 Pemetrexed 1 Omacor 1 Ipilimumab 1 Docetaxel 1 Diarylheptanoids 1 Cisplatin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03598309 2026-02-27

Phase II Trial to Modulate Intermediate Endpoint Biomarkers in Former and Current Smokers

H. Lee Moffitt Cancer Center and Research Institute

Phase 2 Active not recruiting

Lung Diseases, Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡